Can immunohistochemical markers and mitotic rate improve prognostic precision in patients with primary melanoma?

Abstract

Nine immunohistochemical markers with established prognostic significance for primary human melanoma were not found to improve a prognostic model that included tumor thickness, localization, and mitoses. If mitoses was replaced by ulceration, then the model performed slightly better, although ulceration was not significant in the presence of mitoses.